Detalles de la búsqueda
1.
Protective effects of imeglimin on the development of atherosclerosis in ApoE KO mice treated with STZ.
Cardiovasc Diabetol
; 23(1): 105, 2024 Mar 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-38504316
2.
Dipeptidyl peptidase-4 inhibitor and sodium-glucose cotransporter 2 inhibitor additively ameliorate hepatic steatosis through different mechanisms of action in high-fat diet-fed mice.
Diabetes Obes Metab
; 26(6): 2339-2348, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38504118
3.
Protective effects of the SGLT2 inhibitor luseogliflozin on pancreatic ß-cells in db/db mice: The earlier and longer, the better.
Diabetes Obes Metab
; 20(10): 2442-2457, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-29873444
4.
Imeglimin exerts favorable effects on pancreatic ß-cells by improving morphology in mitochondria and increasing the number of insulin granules.
Sci Rep
; 12(1): 13220, 2022 08 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35918386
5.
Early combination therapy of empagliflozin and linagliptin exerts beneficial effects on pancreatic ß cells in diabetic db/db mice.
Sci Rep
; 11(1): 16120, 2021 08 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34373487
6.
Decreased glucagon-like peptide 1 receptor expression in endothelial and smooth muscle cells in diabetic db/db mice: TCF7L2 is a possible regulator of the vascular glucagon-like peptide 1 receptor.
Diab Vasc Dis Res
; 14(6): 540-548, 2017 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-28830217
Resultados
1 -
6
de 6
1
Próxima >
>>